
|Articles|March 1, 2002
The American Journal of Managed Care
- March 2002
- Volume 8
- Issue 3
Changes in Related Drug Class Utilization after Market Withdrawal of Cisapride
Advertisement
Articles in this issue
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Inside the VA’s Hub-and-Spoke Model for Multiple Sclerosis Care: Rebecca Spain, MD
2
Flow Cytometry Tracks CAR T-Cell Therapy Persistence in Aggressive LBCL
3
Newly Identified RTEL1 Variant Could Broaden Genetic Landscape of Familial PF
4
Non-Invasive Tests Show Promise for Tracking Treatment Response in Semaglutide MASH Trial
5















































